Axq Capital, LP Biomarin Pharmaceutical Inc Transaction History

Axq Capital, LP

$428 Billion
Q2 2024

A detailed history of Axq Capital, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Axq Capital, LP holds 20,699 shares of BMRN stock, worth $1.44 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

20,699

Previous 15,300 35.29%

Holding current value

$1.44 Million

Previous $1.34 Billion 27.53%

% of portfolio

0.4%

Previous 0.32%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $401,847 - $497,895	5,399 Added 35.29%	20,699 $1.7 Billion
Q1 2024 May 14, 2024	BUY	$83.81 - $99.0 $930,291 - $1.1 Million	11,100 Added 264.29%	15,300 $1.34 Billion
Q4 2023 Feb 13, 2024	SELL	$76.22 - $98.51 $15,244 - $19,702	-200 Reduced 4.55%	4,200 $405 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $93,576 - $103,928	-1,100 Reduced 20.0%	4,400 $389 Million
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $476,740 - $551,650	5,500 New	5,500 $477 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.9B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.

Account